COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,891 Articles (22,568 medRxiv, 8,323 bioRxiv)

Most recent first Previous |  Page 1228: Articles 12271-12280  | Next

A third dose of inactivated vaccine augments the potency, breadth, and duration of anamnestic responses against SARS-CoV-2
Wang, K., Cao, Y. R., Zhou, Y., Wu, J., Jia, Z., Hu, Y., Yisimayi, A., Fu, W., Wang, L., Liu, P., Fan, K., Chen, R., Wang, L., Jing, L., Wang, Y., Ge, X., Zhang, Q., Wu, J., Wang, N., Wu, W., Gao, Y., Miao, J., Jiang, Y., Qin, L., Zhu, L., Huang, W., Zhang, Y., Zhang, H., Li, B., Gao, Q., Xie, X. S., Wang, Y., Wang, Q., Wang, X.
10.1101/2021.09.02.21261735 — Posted: 2021-09-05
Simultaneous detection of SARS-CoV-2 RNA and host antibodies enabled by a multiplexed electrochemical sensor platform
de Puig, H., Sarma Timilsina, S., Rainbow, J., Jolly, P., Najjar, D., Durr, N., Alter, G., Li, J. Z., Yu, X. G., Walt, D. R., Estrela, P., Collins, J. J., Ingber, D. E.
10.1101/2021.09.01.21262387 — Posted: 2021-09-05
COVID-19 vaccination did not improve employee mental health: A prospective study in an early phase of vaccination in Japan
Sasaki, N., Kuroda, R., Tsuno, K., Imamura, K., Kawakami, N.
10.1101/2021.09.02.21262808 — Posted: 2021-09-05
COVID-19 mortality in children and young people in Mexico
Stern, D., Arias de la Garza, E., Teresa Garcia, M., Lajous, M.
10.1101/2021.09.01.21262981 — Posted: 2021-09-05
The pitfalls of inferring virus-virus interactions from co-detection prevalence data: Application to influenza and SARS-CoV-2
Domenech de Celles, M., Goult, E., Casalegno, J.-S., Kramer, S. C.
10.1101/2021.09.02.21263018 — Posted: 2021-09-05
Impact and effectiveness of social distancing for COVID-19 mitigation -- A transnational and transregional study
Rocha, T. M., Mendes, J. F., Moret, M. A.
10.1101/2021.09.01.21262990 — Posted: 2021-09-05
An Extended Coatomer Binding Motif in the SARS-CoV-2 Spike Protein
Dey, D., Singh, S., Khan, S., Martin, M., Schnicker, N., Gakhar, L., Pierce, B., Hasan, S. S.
10.1101/2021.09.03.458953 — Posted: 2021-09-04
Network analysis outlines strengths and weaknesses of emerging SARS-CoV-2 Spike variants
Manrique, P. D., Chakraborty, S., Nguyen, K., Mansbach, R., Korber, B., Gnanakaran, S.
10.1101/2021.09.03.458946 — Posted: 2021-09-04
Genomic evidence for divergent co-infections of SARS-CoV-2 lineages
Zhou, H.-Y., Cheng, Y.-X., Xu, L., Li, J.-Y., Tao, C.-Y., Ji, C.-Y., Han, N., Yang, R., Li, Y., Wu, A.
10.1101/2021.09.03.458951 — Posted: 2021-09-04
Characteristics associated with COVID-19 vaccine uptake among adults in England (08 December to 17 May 2021)
Tessier, E., Rai, Y., Clarke, E., Lakhani, A., Tsang, C., Makwana, A., Heard, H., Rickeard, T., Lakhani, S., Roy, P., Edelstein, M., Ramsay, M., Lopez Bernal, J., White, J., Andrews, N., Campbell, C., Stowe, J.
10.1101/2021.08.27.21262422 — Posted: 2021-09-04

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).